首页> 外国专利> USE OF CANCER-TARGETING HSP90 ALPHA IN A CANCER CELL EXPOSED UNDER A HYPOXIC CONDITION

USE OF CANCER-TARGETING HSP90 ALPHA IN A CANCER CELL EXPOSED UNDER A HYPOXIC CONDITION

机译:在低氧条件下暴露的癌细胞中靶向癌的HSP90α的使用

摘要

PURPOSE: A cancer-targeting HSP90 alpha in a cancer cell exposed under a hypoxic condition is provided to regulate HSP90 alpha expression through JaK2/STAT5b in a tumor tissue.;CONSTITUTION: A composition for diagnosing cancer contains HSP90 alpha as an active ingredient. Cancer is selected from the group consisting of breast cancer, prostate cancer, ovarian cancer, uterine cervix cancer, skin cancer, malignant melanoma, pancreatic cancer, colorectal cancer, kidney cancer, leukemia, non-small cell carcinoma, and lung cancer. A composition for diagnosing cancer contains a gene encoding HSP90 alpha as an active ingredient.;COPYRIGHT KIPO 2013
机译:目的:在缺氧条件下暴露的癌细胞中提供靶向癌症的HSP90α,以通过JaK2 / STAT5b在肿瘤组织中调节HSP90α的表达。;组成:用于诊断癌症的组合物包含HSP90α作为有效成分。癌症选自乳腺癌,前列腺癌,卵巢癌,子宫颈癌,皮肤癌,恶性黑素瘤,胰腺癌,结肠直肠癌,肾癌,白血病,非小细胞癌和肺癌。用于诊断癌症的组合物包含编码HSP90 alpha的基因作为有效成分。; COPYRIGHT KIPO 2013

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号